Medizinische Hochschule Hannover (MHH) / Hannover Medical School
University / College
Location:
Hannover,
Germany (DE)
ISNI: 0000000095299877
ROR: https://ror.org/00f2yqf98
Differential DNA Damage Response of Peripheral Blood Lymphocyte Populations (2021)
Felgentreff K, Schuetz C, Baumann U, Klemann C, Viemann D, Ursu S, Jacobsen EM, et al.
Journal article
STAT1 coordinates intestinal epithelial cell death during gastrointestinal infection upstream of Caspase-8 (2021)
Stolzer I, Schickedanz L, Chiriac MT, López-Posadas R, Grassl GA, Mattner J, Wirtz S, et al.
Journal article
Value of PET imaging for radiation therapy (2021)
Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, et al.
Journal article, Review article
Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie – Update 2021 (2021)
Ewig S, Kolditz M, Pletz MW, Altiner A, Albrich W, Droemann D, Flick H, et al.
Journal article
Assessment of the Severity of Atopic Dermatitis by Physicians and Patients depending on Gender: Results from the German Atopic Dermatitis Registry TREATgermany (2021)
Heinrich L, Haufe E, Abraham S, Heratizadeh A, Harder , Kleinheinz A, Wollenberg A, et al.
Conference contribution
Fatigue and Atopic Dermatitis: Results from the German Atopic Dermatitis Registery TREATgermany (2021)
Helmert C, Haufe E, Abraham S, Heratizadeh A, Harder , Kleinheinz A, Wollenberg A, et al.
Conference contribution
An ongoing, randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST) (2021)
Ahrens M, Escudier B, Haanen JBAG, Boleti E, Goupil GM, Grimm MO, Negrier S, et al.
Conference contribution
ELDORANDO - Pembrolizumab compared with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115) (2021)
Klinghammer K, Graeven U, Ivanyi P, Dietz A, Hahn D, Hackenberg S, Kasper S, et al.
Conference contribution
Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry (2021)
Kuemmerle-Deschner J, Henes J, Kortus-Goetze B, Kallinich T, Oommen PT, Rech J, Weller-Heinemann F, et al.
Conference contribution
Persistence on JAK Inhibitors in Daily Practice: Evaluation of the Rhadar-registry (2021)
Risser L, Witte T, Bartz-Bazzanella P, Von Der Decken C, Knitza J, Fekete SP, Zink A, et al.
Conference contribution